Data sourced from ClinicalTrials.gov (NIH registry) Updated weekly IRB-supervised studies only
Home/TX/Houston
Updated September 2026 from ClinicalTrials.gov

Paid Clinical Trials in Houston, TX

Studies commonly pay $75 to $4,500 per completed study

3,069 clinical trials are currently recruiting participants within 30 miles of Houston. Listings below come straight from the official NIH registry, alongside the area's top-rated research centers with real Google reviews.

3,069studies recruiting
9+research centers nearby
3condition categories
Live from the NIH registry

Studies recruiting near Houston right now

Top 25 of 3,069 recruiting studies, sorted by proximity — each links to its official registry page

Fludarabine Phosphate, Cytarabine, Filgrastim-sndz, Gemtuzumab Ozogamicin, and Idarubicin Hydrochloride in Treating Patients With Newly Diagnosed Acute Myeloid Leukemia or High-Risk Myelodysplastic Syndrome

Acute Myeloid Leukemia With Inv(16)(p13.1q22); CBFB-MYH11, Acute Myeloid Leukemia With t(16;16)(p13.1;q22); CBFB-MYH11 Phase 2 Interventional 270 participants sought
M D Anderson Cancer Center — Houston, Texas (2.2 mi) · Sponsor: M.D. Anderson Cancer Center
See eligibility & contact on ClinicalTrials.gov (NCT00801489)

TAPUR: Testing the Use of Food and Drug Administration (FDA) Approved Drugs That Target a Specific Abnormality in a Tumor Gene in People With Advanced Stage Cancer

Lymphoma, Non-Hodgkin, Multiple Myeloma Phase 2 Interventional 4,200 participants sought
The University of Texas MD Anderson Cancer Center — Houston, Texas (2.2 mi) · Sponsor: American Society of Clinical Oncology
See eligibility & contact on ClinicalTrials.gov (NCT02693535)

Study of RMC-9805 in Participants With KRAS G12D-Mutant Solid Tumors

Non-small Cell Lung Cancer (NSCLC), Colorectal Cancer (CRC) Phase 1 Interventional 604 participants sought
University of Texas, MD Anderson Cancer Center — Houston, Texas (2.2 mi) · Sponsor: Revolution Medicines, Inc.
See eligibility & contact on ClinicalTrials.gov (NCT06040541)

A Study Testing the Combination of Dasatinib or Imatinib to Chemotherapy Treatment With Blinatumomab for Children, Adolescents, and Young Adults With Philadelphia Chromosome Positive (Ph+) or ABL-Class Philadelphia Chromosome-Like (Ph-Like) B-cell Acute Lymphoblastic Leukemia (B-ALL)

B Acute Lymphoblastic Leukemia Phase 2 Interventional 222 participants sought
Baylor College of Medicine/Dan L Duncan Comprehensive Cancer Center — Houston, Texas (2.2 mi) · Sponsor: National Cancer Institute (NCI)
See eligibility & contact on ClinicalTrials.gov (NCT06124157)

Systemic Therapy of Open-label Prophylactic Pravastatin or Pentoxifylline/Tocopherol Prevention of Lymphedema Advancing to Eventual Fibrosis: an Interventional Registry-embedded Bayesian Randomized Trial for Radiation Sequelae (STOP4-LATE-FIBROSE)

Lymphedema, Fibrosis Phase 2 Interventional 295 participants sought
MD Anderson Cancer Center — Houston, Texas (2.2 mi) · Sponsor: M.D. Anderson Cancer Center
See eligibility & contact on ClinicalTrials.gov (NCT06494111)

Advancing Discussions Using a Video-based Support Tool About End-of-life Care

Traumatic Injury N/A Interventional 270 participants sought
The University of Texas Health Science Center at Houston — Houston, Texas (2.2 mi) · Sponsor: The University of Texas Health Science Center, Houston
See eligibility & contact on ClinicalTrials.gov (NCT06804226)

A Study in People With Diabetic Macular Edema to Test How Well Different Doses of BI 3812465 Are Tolerated

Diabetic Macular Edema Phase 1, Phase 2 Interventional 49 participants sought
Retina Consultants of Texas-Bellaire-67493 — Bellaire, Texas (7.0 mi) · Sponsor: Boehringer Ingelheim
See eligibility & contact on ClinicalTrials.gov (NCT07553429)

Addition of Cord Blood Tissue-Derived Mesenchymal Stromal Cells to Ruxolitinib for the Treatment of Steroid-Refractory Acute Graft Versus Host Disease

Hematopoietic and Lymphoid Cell Neoplasm, Steroid Refractory Graft Versus Host Disease EARLY/Phase 1 Interventional 24 participants sought
M D Anderson Cancer Center — Houston, Texas (2.2 mi) · Sponsor: M.D. Anderson Cancer Center
See eligibility & contact on ClinicalTrials.gov (NCT04744116)

A TRIAL TO EVALUATE THE SAFETY, TOLERABILITY, PHARMACOKINETICS, AND EFFICACY OF SHR-A1904 IN SUBJECTS WITH ADVANCED SOLID TUMORS

Advanced Solid Tumors Phase 1, Phase 2 Interventional 83 participants sought
The University of Texas MD Anderson Cancer Center — Houston, Texas (2.2 mi) · Sponsor: Jiangsu HengRui Medicine Co., Ltd.
See eligibility & contact on ClinicalTrials.gov (NCT05277168)

Implementing a Decision Support Tool to Prevent Community-Acquired Pressure Injury in Spinal Cord Injury (SCI) in the Spinal Cord Injury Clinic

Spinal Cord Injury, Pressure Injury N/A Interventional 808 participants sought
Michael E. DeBakey VA Medical Center, Houston, TX — Houston, Texas (2.2 mi) · Sponsor: VA Office of Research and Development
See eligibility & contact on ClinicalTrials.gov (NCT06529094)

A Study That Collects Participant Data and Biospecimens to Analyze Pathogenic Exosomes That Mediate Increased Vascular Dementia Risk in Individuals With Herpes Zoster.

Herpes Zoster (HZ), Vascular Dementia N/A Observational 375 participants sought
Center for Clinical Studies, LTD. LLP — Houston, Texas (2.2 mi) · Sponsor: Center for Clinical Studies, Texas
See eligibility & contact on ClinicalTrials.gov (NCT06903078)

PATHS-UP Health Behavior Self-monitoring Mobile App for Adolescents

Obesity and Diabetes Mellitus, Type 2, Diabetes Prevention N/A Interventional 30 participants sought
Children's Nutrition Research Center — Houston, Texas (2.2 mi) · Sponsor: Baylor College of Medicine
See eligibility & contact on ClinicalTrials.gov (NCT06959901)

DESTINY-Endometrial01: A Phase III Study of Trastuzumab Deruxtecan Plus Rilvegostomig or Pembrolizumab as First-Line Treatment of HER2-Expressing (IHC 3+/2+), Mismatch Repair Proficient (pMMR) Endometrial Cancer

Endometrial Cancer Phase 3 Interventional 600 participants sought
Research Site — Houston, Texas (2.2 mi) · Sponsor: AstraZeneca
See eligibility & contact on ClinicalTrials.gov (NCT06989112)

A Study of BG-75098 Alone and in Combination With Other Agents in Adults With Advanced Solid Tumors

Advanced Solid Tumor Phase 1 Interventional 105 participants sought
The University of Texas Md Anderson Cancer Center — Houston, Texas (2.2 mi) · Sponsor: BeOne Medicines
See eligibility & contact on ClinicalTrials.gov (NCT07226349)

MSC-DNX-2401 in Treating Patients With Recurrent High-Grade Glioma

IDH1 wt Allele, Recurrent Anaplastic Astrocytoma Phase 1 Interventional 36 participants sought
M D Anderson Cancer Center — Houston, Texas (2.2 mi) · Sponsor: M.D. Anderson Cancer Center
See eligibility & contact on ClinicalTrials.gov (NCT03896568)

PEP-CMV Vaccine Targeting CMV Antigen to Treat Newly Diagnosed Pediatric HGG and DIPG and Recurrent Medulloblastoma

High Grade Glioma, Diffuse Intrinsic Pontine Glioma Phase 2 Interventional 120 participants sought
Texas Children's Hospital — Houston, Texas (2.2 mi) · Sponsor: Nationwide Children's Hospital
See eligibility & contact on ClinicalTrials.gov (NCT05096481)

International obServational sTudy on AiRway manaGement in operAting Room and Non-operaTing Room anaEsthesia

Airway Complication of Anesthesia N/A Observational 10,500 participants sought
MD Anderson Cancer Center — Houston, Texas (2.2 mi) · Sponsor: University of Turin, Italy
See eligibility & contact on ClinicalTrials.gov (NCT05759299)

A Dose Escalation and Dose Expansion Study of Intratumoral ONM-501 Alone and in Combination With Cemiplimab in Patients With Advanced Solid Tumors and Lymphomas.

Triple Negative Breast Cancer, Diffuse Large B Cell Lymphoma Phase 1 Interventional 168 participants sought
MD Anderson Cancer Center — Houston, Texas (2.2 mi) · Sponsor: OncoNano Medicine, Inc.
See eligibility & contact on ClinicalTrials.gov (NCT06022029)

Adapting and Assessing the Feasibility of a Telehealth Diabetes Prevention Program for Hispanic Adolescents

Obesity and Type 2 Diabetes N/A Interventional 40 participants sought
USDA/ARS Children's Nutrition Research Center, Baylor College of Medicine — Houston, Texas (2.2 mi) · Sponsor: Baylor College of Medicine
See eligibility & contact on ClinicalTrials.gov (NCT06943001)

A Study of ERAS-0015 in Patients With Advanced or Metastatic Solid Tumors

Metastatic Solid Tumors Phase 1 Interventional 600 participants sought
The University of Texas MD Anderson Cancer Center — Houston, Texas (2.2 mi) · Sponsor: Erasca, Inc.
See eligibility & contact on ClinicalTrials.gov (NCT06983743)

A Study to Evaluate the Efficacy of Pumitamig Versus Pembrolizumab in Participants With Previously Untreated Advanced Non-Small Cell Lung Cancer and PD-L1 ≥ 50%. (ROSETTA Lung-202)

Non-Small Cell Lung Cancer (NSCLC) Phase 3 Interventional 750 participants sought
Kelsey-Seybold Clinic Main Campus — Houston, Texas (2.2 mi) · Sponsor: Bristol-Myers Squibb
See eligibility & contact on ClinicalTrials.gov (NCT07361510)
Actively enrolling

Studies you may be able to join near Houston

These studies are recruiting through partner research networks. We may be paid a referral fee if you complete their screening form — this never changes what you pay (nothing) or the compensation the study offers you.

Research study for alcohol-related liver damage

Enrolling US adults aged 18 to 70 with alcohol-induced liver damage and a history of heavy drinking. Not open to people with a recent stroke, heart attack, dialysis, or who take blood thinners.

Screening is free and takes a few minutes. Eligibility and any compensation are confirmed by the study team, not by this site.

Check your eligibility

Research studies for chronic kidney disease

This research platform is enrolling Black and African American adults in eligible areas who have been diagnosed with chronic kidney disease. Compensation may be available. The study team confirms eligibility before enrollment.

Screening is free and takes a few minutes. Eligibility and any compensation are confirmed by the study team, not by this site.

Check your eligibility

Research study for bladder problems after spinal cord injury

This study is enrolling US adults aged 18 to 75 living with chronic involuntary bladder leakage caused by a spinal cord injury, for research including investigational gene therapy approaches. The study team confirms eligibility and any compensation before enrollment.

Screening is free and takes a few minutes. Eligibility and any compensation are confirmed by the study team, not by this site.

Check your eligibility
Google-rated

Top-rated research centers in Houston

Dedicated clinical research sites near you — with their real Google ratings, reviews and contact details

HD Research

★ 3.8
1917 Ashland St, Houston, TX 77008
(281) 369-5765
"Horribly rude lady called to ask questions and just be mean and judgey about ny answers. 0/10 this is a scam."
— Frank Leger, 1★

Helios Clinical Research - Houston

1919 N Loop W Fwy #250, Houston, TX 77008
(214) 550-3029

Spring Clinical Research

★ 4.4
2000 Crawford St Ste 1125, Houston, TX 77002
(281) 888-5564

Clinical Trials - CliniCore Research

★ 5.0
4200 Twelve Oaks Pl, Houston, TX 77027
(713) 589-6400

Center for Clinical Studies

★ 5.0
1401 Binz St Unit 200, Houston, TX 77004
(281) 343-3300

DM Clinical Research - Bellaire (Formerly TCDD)

★ 4.9
6550 Mapleridge St #201, Houston, TX 77081
(346) 550-9559
"Great facility for clinical trials and safe way to make money while helping our community."
— Dav “Shag Dog” Boer, 5★

West Houston Clinical Research Service LLC

★ 4.3
2026 Wirt Rd, Houston, TX 77055
(281) 738-2642

Prolato Clinical Research Center

★ 4.7
8990 Kirby Dr Ste 208, Houston, TX 77054
(832) 338-9118
"I feel really grateful for this place, staff were very kind and informative. If you’re looking for a place for clinical research for you or a family …"
— Doirisdel Marcano, 5★

Houston Clinical Trials by Power

3139 W Holcombe Blvd A183, Houston, TX 77025

Clinical trials in Houston: what's recruiting

The Houston area currently has 3,069 studies open to new participants, according to the ClinicalTrials.gov registry maintained by the U.S. National Institutes of Health. Among the studies closest to Houston, the most active research areas are:

  • Cancer & Oncology14 studies
  • Diabetes & Metabolism3 studies
  • Heart & Vascular1 studies

Every listing shows the study phase, the recruiting site and its distance from Houston, and links to the official registry page where eligibility criteria and study contacts are published. Compensation is set by each sponsor: industry surveys report typical payments of $75 to $4,500 per completed study, with short observational studies at the low end and multi-visit or overnight Phase 1 studies at the high end.

How to enroll in a paid study in Houston

Start with a study whose condition matches your profile — or a healthy-volunteer study if you have no diagnosis. Contact the research site through the registry page, complete a short phone screen, then attend an in-person screening visit. If you qualify, the study team walks you through the informed consent document, which details every procedure, risk and payment before you commit. You can withdraw at any point, and enrollment is always free.

Houston participants can also register with the dedicated research centers listed above — many maintain volunteer databases and call when a matching study opens — or sign up for our email alert below to hear when a new study starts recruiting within 30 miles of your ZIP code.

Frequently asked questions

How much do paid clinical trials in Houston pay?
Compensation varies by study length, procedures and overnight stays. Industry surveys report typical payments from $75 to $4,500 per completed study, with simple observational studies at the low end and multi-week inpatient Phase 1 studies at the high end. Each listing's study team will confirm the exact amount before you enroll.
Are clinical trials in Houston safe?
Every trial on this page is registered on ClinicalTrials.gov, the official NIH registry, and is overseen by an Institutional Review Board (IRB). Before joining you receive an informed consent document detailing procedures, risks and compensation. Participation is voluntary and you can withdraw at any time.
Is compensation for clinical trials taxable?
In the U.S., clinical trial compensation is generally considered taxable income, and research sites may issue a 1099 form for payments above $600 in a year. Reimbursements for travel or meals are typically treated differently. Consult a tax professional for your situation.
How often do new paid studies open in Houston?
Constantly — trials open and close enrollment every week. This page is refreshed weekly from the NIH registry. Join the email alert to be notified when a new study opens within 30 miles of Houston.
Can I be in more than one clinical trial at a time?
Generally no — most studies exclude participants currently enrolled in another trial, and paid Phase 1 studies enforce a washout period (often 30 days or more) between studies. Frequent healthy volunteers in Houston typically complete one or two studies per year.

Paid clinical trials near Houston

Other metros within reach

Pasadena, TX3,010 Galveston, TX204 College Station, TX46 Beaumont, TX44 Lake Charles, LA28 Austin, TX738 Waco, TX53 Killeen, TX105

By condition

Eligibility and exclusions, condition by condition

Alcoholic Liver Disease in Houston Chronic Kidney Disease (HealthMatch) in Houston Bladder Issues Due To Spinal Cord Injury in Houston All conditions

More of TX

Pasadena3,010 Irving1,988 Grand Prairie1,956 Arlington1,871 Dallas1,868 Garland1,830 Plano1,825 Frisco1,824 Mesquite1,771 San Antonio1,010 Austin738

New paid studies open every week

Get an email when a new clinical trial starts recruiting within 30 miles of your ZIP code. No spam — only real studies from the NIH registry.

By subscribing you agree to receive study alert emails. Unsubscribe anytime in one click.

Get free trial alerts